PURPOSE: The purpose of this study was to evaluate the diagnostic value of interleukin-6 (IL-6) and other inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WCC) in diagnosis of PJI. METHODS: The study group included 40 patients (21 males, 19 females) admitted for surgical intervention after knee or hip arthroplasties. Patients were subjected to careful history taking, thorough clinical examination and pre-operative laboratory investigations including serum IL-6, CRP, WCC and ESR. Peri-implant tissue specimens were subjected to microbiological culture and histopathological examination. RESULTS: The mean age of patients was 58.4 years (range, 38-72 years). Intra-operative cultures and histopathological examination revealed 11 patients had been infected (PJI) and 29 patients were aseptic failure of prosthesis. Four presumed markers of infection were tested preoperatively: ESR, CRP, WCC, and IL-6. ESR (p = 0.0001), CRP (p = 0.004), WCC (0.0001), and IL-6 (p = 0.0001) were significantly higher in patients with septic revision than those with aseptic failure of the prosthesis. Serum IL-6 (>10.4 pg/ml) reportedly had a sensitivity of 100%, a specificity of 90.9%, a PPV of 79%, a NPV of 100%, and accuracy of 92.5%. CONCLUSIONS: The present study demonstrated that IL-6 has been found to be the most accurate laboratory marker for diagnosing PJI when compared to ESR, CRP, and WCC. IL-6 above 10.4 pg/ml and CRP level above 18 mg/L will identify all patients with PJI and the combination of CRP + IL-6 is an excellent screening test to identify all such patients (sensitivity 100%, NPV 100%).
PURPOSE: The purpose of this study was to evaluate the diagnostic value of interleukin-6 (IL-6) and other inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WCC) in diagnosis of PJI. METHODS: The study group included 40 patients (21 males, 19 females) admitted for surgical intervention after knee or hip arthroplasties. Patients were subjected to careful history taking, thorough clinical examination and pre-operative laboratory investigations including serum IL-6, CRP, WCC and ESR. Peri-implant tissue specimens were subjected to microbiological culture and histopathological examination. RESULTS: The mean age of patients was 58.4 years (range, 38-72 years). Intra-operative cultures and histopathological examination revealed 11 patients had been infected (PJI) and 29 patients were aseptic failure of prosthesis. Four presumed markers of infection were tested preoperatively: ESR, CRP, WCC, and IL-6. ESR (p = 0.0001), CRP (p = 0.004), WCC (0.0001), and IL-6 (p = 0.0001) were significantly higher in patients with septic revision than those with aseptic failure of the prosthesis. Serum IL-6 (>10.4 pg/ml) reportedly had a sensitivity of 100%, a specificity of 90.9%, a PPV of 79%, a NPV of 100%, and accuracy of 92.5%. CONCLUSIONS: The present study demonstrated that IL-6 has been found to be the most accurate laboratory marker for diagnosing PJI when compared to ESR, CRP, and WCC. IL-6 above 10.4 pg/ml and CRP level above 18 mg/L will identify all patients with PJI and the combination of CRP + IL-6 is an excellent screening test to identify all such patients (sensitivity 100%, NPV 100%).
Authors: Nathan G Wetters; Keith R Berend; Adolph V Lombardi; Michael J Morris; Tawnya L Tucker; Craig J Della Valle Journal: J Arthroplasty Date: 2012-05-17 Impact factor: 4.757
Authors: Hany Bedair; Nicholas Ting; Christina Jacovides; Arjun Saxena; Mario Moric; Javad Parvizi; Craig J Della Valle Journal: Clin Orthop Relat Res Date: 2011-01 Impact factor: 4.176
Authors: Esa Jämsen; Markku Varonen; Heini Huhtala; Matti U K Lehto; Jukka Lumio; Yrjö T Konttinen; Teemu Moilanen Journal: J Arthroplasty Date: 2008-12-04 Impact factor: 4.757
Authors: Sascha Gravius; Thomas M Randau; Rita Casadonte; Mark Kriegsmann; Max J Friedrich; Jörg Kriegsmann Journal: Int Orthop Date: 2014-10-03 Impact factor: 3.075
Authors: Arnold J Suda; Marco Tinelli; Nils D Beisemann; Yoram Weil; Amal Khoury; Oliver E Bischel Journal: Int Orthop Date: 2017-02-04 Impact factor: 3.075
Authors: Sufian S Ahmad; Ahmed Shaker; Mo Saffarini; Antonia F Chen; Michael T Hirschmann; Sandro Kohl Journal: Knee Surg Sports Traumatol Arthrosc Date: 2016-07-05 Impact factor: 4.342